Advanced in Gastroesophageal Reflux Disease (GERD)

Dr. Mirna J. Chehade

Pediatric Gastroenterology | Pediatrics
1 Gustave L Levy Pl, Box 1200, 
New York, NY 
Advanced in Gastroesophageal Reflux Disease (GERD)
1 Gustave L Levy Pl, Box 1200, 
New York, NY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Mirna Chehade is a Pediatric Gastroenterologist and a Pediatrics provider in New York, New York. Dr. Chehade is rated as an Advanced provider by MediFind in the treatment of Gastroesophageal Reflux Disease (GERD). Her top areas of expertise are Eosinophilic Esophagitis, Esophagitis, Gastritis, Eosinophilic Enteropathy, and Endoscopy.

Her clinical research consists of co-authoring 126 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 5 articles in the study of Gastroesophageal Reflux Disease (GERD).

Specialties
Pediatric Gastroenterology
Pediatrics
Licenses
Pediatric Gastroenterology in NY
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health First
  • HMO
  • POS
HealthPartners
  • POS
  • PPO
Horizon Healthcare
  • EPO
  • POS
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 9 Less Insurance Carriers -

Locations

1 Gustave L Levy Pl, Box 1200, New York, NY 10029

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase 3, Multicenter, Open-label Continuation Study With Budesonide Oral Suspension (BOS) for Adolescent and Adult Subjects With Eosinophilic Esophagitis (EoE)
A Phase 3, Multicenter, Open-label Continuation Study With Budesonide Oral Suspension (BOS) for Adolescent and Adult Subjects With Eosinophilic Esophagitis (EoE)
Enrollment Status: Terminated
Publish Date: February 19, 2025
Intervention Type: Drug
Study Drug: Budesonide oral suspension
Study Phase: Phase 3
A Phase 3, Multicenter, Double-blind Extension Study to Evaluate Maintenance of Efficacy of Oral Budesonide Suspension (OBS) and Long-term Treatment Effect of OBS in Adolescent and Adult Subjects (11 to 55 Years of Age, Inclusive) With Eosinophilic Esophagitis (EoE)
A Phase 3, Multicenter, Double-blind Extension Study to Evaluate Maintenance of Efficacy of Oral Budesonide Suspension (OBS) and Long-term Treatment Effect of OBS in Adolescent and Adult Subjects (11 to 55 Years of Age, Inclusive) With Eosinophilic Esophagitis (EoE)
Enrollment Status: Completed
Publish Date: February 19, 2025
Intervention Type: Drug
Study Phase: Phase 3
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11 to 55 Years of Age, Inclusive) With Eosinophilic Esophagitis: A Phase 3 Randomized, Double-blind, Placebo-controlled Study
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11 to 55 Years of Age, Inclusive) With Eosinophilic Esophagitis: A Phase 3 Randomized, Double-blind, Placebo-controlled Study
Enrollment Status: Completed
Publish Date: February 19, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamic Effect of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamic Effect of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis
Enrollment Status: Completed
Publish Date: January 19, 2024
Intervention Type: Other, Drug
Study Phase: Phase 2
View 3 Less Clinical Trials

126 Total Publications

Dupilumab Improves Multiple Aspects of Dysphagia Symptoms in a Randomized Trial of Eosinophilic Esophagitis.
Dupilumab Improves Multiple Aspects of Dysphagia Symptoms in a Randomized Trial of Eosinophilic Esophagitis.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: June 03, 2025
Similar Doctors
Distinguished in Gastroesophageal Reflux Disease (GERD)
Dr. Joel Portnoy
Otolaryngology | Pediatrics
Distinguished in Gastroesophageal Reflux Disease (GERD)
Dr. Joel Portnoy
Otolaryngology | Pediatrics

ENT & Allergy Associates - Lake Success

6 Ohio Drive, Suite 202, 
New Hyde Park, NY 
 (13.7 miles away)
516-775-2800
Languages Spoken:
English
See accepted insurances

Joel Portnoy is a Pediatrics provider in New Hyde Park, New York. Dr. Portnoy is rated as a Distinguished provider by MediFind in the treatment of Gastroesophageal Reflux Disease (GERD). His top areas of expertise are Spasmodic Dysphonia, Vocal Cord Dysfunction, Laryngitis, and Gastroesophageal Reflux Disease (GERD).

Distinguished in Gastroesophageal Reflux Disease (GERD)
Dr. Jeffrey Cousin
Otolaryngology | Pediatrics
Distinguished in Gastroesophageal Reflux Disease (GERD)
Dr. Jeffrey Cousin
Otolaryngology | Pediatrics

ENT & Allergy Associates - Yonkers

1086 N. Broadway, Suite 220, 
Yonkers, NY 
 (13.1 miles away)
914-963-8588
Languages Spoken:
English
See accepted insurances

Jeffrey Cousin is a Pediatrics provider in Yonkers, New York. Dr. Cousin is rated as a Distinguished provider by MediFind in the treatment of Gastroesophageal Reflux Disease (GERD). His top areas of expertise are Jones Syndrome, Infant Hearing Loss, DFNB1, and Nonallergic Rhinopathy.

Distinguished in Gastroesophageal Reflux Disease (GERD)
Dr. Kamran Sadrazodi
Otolaryngology | Pediatrics
Distinguished in Gastroesophageal Reflux Disease (GERD)
Dr. Kamran Sadrazodi
Otolaryngology | Pediatrics

ENT & Allergy Associates - Fresh Meadows

163-03 Horace Harding Expressway, Third Floor, 
Fresh Meadows, NY 
 (8.5 miles away)
718-445-5100
Languages Spoken:
English
See accepted insurances

Kamran Sadrazodi is a Pediatrics provider in Fresh Meadows, New York. Dr. Sadrazodi is rated as a Distinguished provider by MediFind in the treatment of Gastroesophageal Reflux Disease (GERD). His top areas of expertise are Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), Nonallergic Rhinopathy, Ozena, and Palatal Myoclonus.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Chehade's expertise for a condition
ConditionClose
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile